Navigation Links
Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease
Date:7/15/2009

SCOTTSDALE, Ariz., July 15 /PRNewswire-USNewswire/ -- Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

These and other findings reported by researchers and their colleagues in the Arizona Alzheimer's Consortium support the possibility that future Alzheimer's treatments may be most effective if started in middle-aged people, years before the onset of disabling memory and thinking problems or extensive brain pathology.

The study, which followed participants for up to 14 years, used sensitive memory and thinking tests to detect, track and compare cognitive performance in 815 healthy people, 21 to 97 years of age, with two copies, one copy and no copies of the APOE e4 gene, the major genetic risk factor for developing Alzheimer's disease at older ages. Each additional copy of this gene is associated with a higher risk of Alzheimer's disease and a slightly younger age at the onset of clinically significant memory and thinking problems.

Approximately one out of four people have one copy of the APOE e4 gene, which was inherited from one parent, and about 2 percent have two copies, which were inherited from both parents.

"We found that memory declines begin to differentiate groups of people at these three levels of genetic risk starting between ages 55 and 60, years earlier than previously suspected, and well before the anticipated onset of clinically significant symptoms," said Rich
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014 Research and Markets ... Balloon Market Investment Report, 2014-2016" report to their ... medical device in percutaneous coronary intervention (PCI), serves not ... as a device for pre-/post-stent dilatations. Therefore, the development ... of PCI. As national economy develops and ...
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... companies. Competition for innovation, increasing clinical development costs, ... with the fast-changing environment are important factors driving ... and clinical trial costs continue to rise due ... Studies conducted by industry think tanks suggest ...
(Date:9/18/2014)... 2014  KIYATEC announced today that it has ... Research (SBIR) Phase II Contract from the National ... and centers that comprise the National Institutes of ... year award, KIYATEC will expand its 3D breast ... forefront of cancer therapy strategies: 1) cancer,s interaction ...
Breaking Medicine Technology:China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3National Cancer Institute Awards KIYATEC Nearly $2M to Advance Predictive Cancer Diagnostics 2National Cancer Institute Awards KIYATEC Nearly $2M to Advance Predictive Cancer Diagnostics 3
... (NASDAQ: OPTR ) today announced the presentation ... (DDW) conference highlighting additional analyses of data from Phase ... the treatment of Clostridium difficile infection (CDI). ... first analysis aimed to identify risk factors associated with ...
... MINNEAPOLIS, May 9, 2011 BioDrain Medical, Inc. (OTC ... FDA-cleared Streamway™ System for automated surgical fluid disposal, announced ... ("EKN"), a New York-based registered broker/dealer, as its exclusive ... terms of the agreement, EKN will assist the Company ...
Cached Medicine Technology:Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 2Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 3Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data 4BioDrain Medical, Inc. Retains EKN Financial Services as Its Exclusive Financial Advisor and Placement Agent 2BioDrain Medical, Inc. Retains EKN Financial Services as Its Exclusive Financial Advisor and Placement Agent 3
(Date:9/18/2014)... Savannah, GA (PRWEB) September 18, 2014 ... awarded the Alex Ormond, Jr. Leadership Award by the ... toward improving healthcare and wellness throughout the nation and ... to receive this award,” said Ben. “The Savannah Science ... for 65 years and multiple generations have gone through ...
(Date:9/18/2014)... will convene a one-day conference at the Milken Institute ... on September 25, 2014 to discuss the Global Health ... The purpose of this event is to invite discussion ... five years, including action plans to curtail the current ... the GHSA, international organizations and more than 50 countries ...
(Date:9/18/2014)... the Ebola virus invoke scary scenarios of deadly epidemics, ... are still providing researchers with new insights on how ... published online Sept. 18, 2014, in the journal ... Medical School Singapore detail how the Yersinia pestis bacteria ... the lymph nodes and eventually ride into the lungs ...
(Date:9/18/2014)... 18, 2014 As testosterone treatment ... U.S. courts, Bernstein Liebhard LLP notes that a ... Food & Drug Administration (FDA) subject prescription low ... could greatly reduce their use. The joint meeting ... Advisory Committee, and the Drug Safety and Risk ...
(Date:9/18/2014)... Once again, Hickman’s Family Farms will partner with ... to celebrate PJs & Eggs. The sixth annual event ... 10, 2014. The “breakfast for dinner” will begin at ... Association (AzCA) foster care programs statewide. , Customers ... on October 10 are invited to wear their pajamas ...
Breaking Medicine News(10 mins):Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Non-governmental stakeholders to discuss the Global Health Security Agenda 2Health News:New insights on an ancient plague could improve treatments for infections 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 2Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 3Health News:Testosterone Treatment News: Bernstein Liebhard LLP Notes Experts’ Recommendations for New Restrictions on Low Testosterone Therapy 4Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2
... Mann HealthDay Reporter , THURSDAY, Feb. 16 (HealthDay ... be a hidden source of arsenic, new research suggests. ... brown rice syrup, is found in some infant formulas. Their ... Health Perspectives . Arsenic is a natural element that ...
... delivery directly into muscle using an autoinjector is faster ... according to a study sponsored by the National Institutes ... School of Medicine researcher. The trial compared the ... how they are administered to patients suffering prolonged seizures ...
... , THURSDAY, Feb. 16 (HealthDay News) -- Doing ... that all Americans must have health insurance would not ... insurance exchanges, but would significantly reduce the number of ... findings from the RAND Corporation, a nonprofit research organization, ...
... Mann HealthDay Reporter , WEDNESDAY, Feb. 15 ... help problem drinkers cut their alcohol consumption, a small ... curbs drinking is not fully understood, but its use ... sadness and nausea, thereby blunting the pleasurable effects of ...
... Reporter , WEDNESDAY, Feb. 15 (HealthDay News) -- Researchers report ... kicking off puberty in humans, a finding that offers insight ... who suffer from a rare disease that prevents the start ... family whose members have suffered from the disease confirmed that ...
... Feb. 15 (HealthDay News) -- How fast you walk or how ... odds for dementia or stroke later in life, a new study ... performed in a doctor,s office, noted study author Dr. Erica C. ... tested the walking speed, hand grip strength and cognitive function of ...
Cached Medicine News:Health News:Arsenic Might Be Found in Some Organic Foods: Study 2Health News:Arsenic Might Be Found in Some Organic Foods: Study 3Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 2Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 3Health News:Wayne State research reveals improved method for paramedics to stop prolonged seizures 4Health News:Health Insurance 'Mandate' Deemed Best Value for Money 2Health News:Stop-Smoking Drug May Also Curb Problem Drinking 2Health News:Gene Linked to Start of Puberty 2Health News:Can Walking Speed, Hand Grip in Middle Age Predict Dementia Risk? 2
... Ad-Techs Foramen Ovale Electrodes provide you ... These electrodes offer the same proven design ... that they are placed using an introducing ... a smaller electrode body diameter, 3 to ...
... The Small Joint Ball Electrode ... in small joint applications. With its ... tip, controlled capsuloligamentous or tendinous tissue ... When used in conjunction with the ...
... is designed to replace the carpal scaphoid bone. ... pole which fits under a shelf formed in ... suture hole on the proximal hole for suture ... the early postoperative period until a firm capsuloligamentous ...
... two-piece Titanium (Ti-6Al-4V) screw offered in two ... of lengths. The two pieces are loaded ... A single instrument set contains all items ... Standard and Mini Kompressor Compression Screws. , ...
Medicine Products: